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Abstract
Deletions in Plasmodium falciparum histidine rich protein 2(pfhrp2) gene threaten the use-
fulness of the most widely used HRP2-based malaria rapid diagnostic tests (mRDTs) that
cross react with its structural homologue, PfHRP3. Parasites with deleted pfhrp2/3 genes
remain undetected and untreated due to ‘false-negative’ RDT results. As Ethiopia recently
launched malaria elimination by 2030 in certain selected areas, the availability of RDTs and
the scale of their use have rapidly increased in recent years. Thus, it is important to explore
the presence and prevalence of deletion in the target genes, pfhrp2 and pfhrp3. From a total
of 189 febrile patients visited Adama Malaria Diagnostic centre, sixty-four microscopically-
and polymerase chain reaction (PCR)-confirmed P. falciparum clinical isolates were used to
determine the frequency of pfhrp2/3 gene deletions. Established PCR assays were applied
to DNA extracted from blood spotted onto filter papers to amplify across pfhrp2/3 exons and
flanking regions. However, analysis of deletions in pfhrp2, pfhrp3 and flanking genomic
regions was successful for 50 of the samples. The pfhrp2 gene deletion was fixed in the pop-
ulation with all 50(100%) isolates presenting a deletion variant. This deletion extended
downstream towards the Pf3D7 0831900 (MAL7PI.230) gene in 11/50 (22%) cases. In con-
trast, only 2/50 (4%) of samples had deletions for the Pf3D7 0831700 (MALPI.228) gene,
upstream of pfhrp2. Similarly, the pfhrp3 gene was deleted in all isolates (100%), while 40%
of the isolates had an extension of the deletion to the downstream flanking region that codes
for Pf3D7 13272400 (MAL13PI.485).The pfhrp3 deletion also extended upstream to Pf3D7
081372100 (MAL13PI.475) region in 49/50 (95%) of the isolates, exhibiting complete
absence of the locus. Although all samples showed deletions of pfhrp2 exon regions, ampli-
fication of an intron region was successful in five cases. Two different repeat motifs in the
intron regions were observed in the samples tested. Pfhrp2/3 gene deletions are fixed in
Ethiopia and this will likely reduce the effectiveness of PfHRP2-based mRDTs. It will be
important to determine the sensitivity PfHRP 2/3-based RDTs in these populations and con-
duct a countrywide survey to determine the extent of these deletions and its effect on routine
RDT-based malaria diagnosis.
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Introduction
In Ethiopia, Plasmodium falciparum and Plasmodium vivax are co-transmitted and respec-
tively accounted for 60% and 40% of all malaria cases [1,2]. Nearly 68% of the landmass of
Ethiopia is favourable for malaria transmission [1] and endemicity is heterogeneous with var-
ied epidemiological presentation in different geographic settings [3]. Like in many parts of
Africa, the incidence of malaria has substantially declined with a reported 40% reduction
between 2000 and 2015 [4,5]. Ethiopia is on track to achieve the 2020 milestone to reduce the
incidence of malaria by 40%. This also aligns with the World Health Organization (WHO)
Global Technical Strategy (GTS) to intensify existing malaria interventions towards elimina-
tion by 2030 [5].
Rapid diagnostic tests (RDTs) were also introduced to improve early diagnosis of malaria
in remote areas where microscopic examination of blood smears remains impractical. A
majority of commercially available mRDTs are designed to detect malaria specific antigens
such as lactate dehydrogenase or aldolase for pan-malaria diagnosis and PfHRP2 for P. falcipa-
rum specific diagnosis [6]. RDTs have become extremely essential for implementing early
diagnosis and prompt effective treatment of malaria and for the continuous reduction of its
burden.
In Ethiopia, mRDTs were introduced as one of the diagnostic methods following the revi-
sion of malaria diagnosis and treatment guideline in 2004 in the country. Depending on the
antigen they target, different types of RDTs exist. Those that target histidine-rich protein-2
(HRP-2) only detect P. falciparum, while those that target the parasite enzyme lactate dehydro-
genase (LDH) and aldolase can detect non-falciparum from mixed infection [7,8]. PfHRP2/
3-based RDTs have been widely used for detection of P. falciparum at health posts/community
levels in Ethiopia since 2005 [9].
PfHRP2 is a non-essential protein encoded by pfhrp2 gene located on chromosome 8 of P.
falciparum. Its structural homologue, PfHRP3, is coded by a locus on chromosome 13 [10].
Pfhrp3 antigen epitopes are recognised by some PfHRP2-based RDTs [11] and may influence
the diagnostic performance of these mRDTs. Hence, PfHRP3 contributes to reactivity of
PfHRP2-based RDTs. Although PfHRP2-based RDTs have been widely used, its performance is
complicated by the natural deletion of pfhrp2 gene in parasite populations in some geographical
regions. Variation in the performance of RDTs has been observed, probably driven by polymor-
phisms in gene loci targeted, such as the recently described deletions in the Pfhrp2/3 loci. The
prevalence and dynamics of these pfhrp2/3 deleted P. falciparum strains and their impact on
diagnosis has not been extensively investigated in Ethiopia. Following the first report detailing
the deletion of the pfhrp2 gene in P. falciparum isolates from Peru, several studies have shown
the global spread of malaria parasites lacking pfhrp2 gene and the flanking chromosomal
regions [12]. This generated anxiety on possible reduced sensitivity of PfHRP2-based RDTs. In
Eritrea, P. falciparum lacking pfhrp2 now constitute a major threat to malaria control [13,14] as
they are not detected by PfHRP2-based RDTs and remain untreated. It has been suggested that
these strains with deletions at pfhrp2/3 genes have a fitness advantage and pose a challenge to
progress made in malaria control and elimination [15] as these parasites will escape detection
by PfHRP2-based RDTs and may be selected to expand due to routine use of RDTs leading to
increasing frequencies of parasite population with pfhrp2/3 deleted genes in the communities.
Though P. falciparum strains without these loci continue to thrive, the role of PfHRP2/3 loci in
parasite virulence and fitness is not clear as these are expressed in all stages of development of
parasite, probably contributing to survival advantage [16–18].
A substantial proportion of parasite isolates with both pfhrp2 and pfhrp3 gene deletions
have been reported across malaria endemic countries in Africa with the highest prevalence of
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deletion from Eritrea (62%) [14] and the lowest from Angola (0.4%) [19]. Indeed, in some hos-
pitals in Eritrea the levels of gene deletions were as high as 80% [14]. As the malaria transmis-
sion intensity and intervention history in Ethiopia is similar to that in Eritrea, it is therefore
possible that pfhrp2/3 deleted isolates may be in circulation in Ethiopia at similarly high fre-
quencies. Following the WHO recommendation for pfhrp2/3 surveys and cross border surveil-
lance activities, this study investigates the extent of pfhrp2/3 deleted P. falciparum parasites in
an Ethiopian P. falciparum population. Molecular analyse targeting the region across exons
and flanking genes were used to provide evidence of gene deletions in the pfhrp2/3 genes.
Materials and methods
Study area
The study was conducted in Adama town, East Shoa Zone, Oromia, Ethiopia. The town is
located at 8.54˚N and 39.27˚E, at an elevation of 1,712 meters above sea levels and is 99 km
southeast of Ethiopia’s capital, Addis Ababa. Located between the base of an escarpment in the
West and the Great Rift Valley in the East, Adama town experiences rainfall from mid-June to
mid-September with short rains in March. Adama Malaria diagnostic center is the oldest labo-
ratory exclusively committed to malaria diagnosis. As a matter of fact, people from the Adama
town and the surrounding rural areas preferentially use this laboratory as far as malaria diag-
nosis is concerned over hospitals and other surrounding health centers in the town. The study
site exhibits high malaria transmission with both P.falciparum and P.vivax malaria are co-
endemic. In the study area, major and minor transmission seasons exist. The major malaria
transmission season is from September through November and the minor from April to May.
Anopheles arabiensis is the dominant malaria vector.
Sample collection and diagnosis of malaria. The study was initiated to explore the
genetic variation and deletions in the pfhrp2/3 genes. Finger-prick blood samples were col-
lected from 64 febrile patients attending Adama Malaria Diagnostic Centre from September
through December 2015. Thick and thin blood smears were prepared for microscopic diagno-
sis of malaria parasite infections and identification of species. Parasite densities were calculated
according to described standard methods (Parasites/μL = no. of asexual parasites X 8000/no.
of WBC counted) [1]. Infected blood samples were spotted onto Whatman 3MM filter papers
for parasite DNA extraction.
PCR confirmation of Plasmodium falciparum infections
Parasite DNA was extracted from dried blood spots using the chelex100 extraction method as
described earlier [20]. The presence of Plasmodium species was confirmed by targeting 18S
rRNA by a nested polymerase chain reaction (nPCR) using genus-specific primers rPLU 6:
(5’TTAAAATTGTTGCAGTTAAAACG3’), rPLU 5: (5’CCTGTTGTTGCCTTAAACTTC3’)
followed by species-specific primers rFAL 1: (5’TTAAACTGGTTTGGGAAAACCAAATAT
ATT3’), rFAL2: (5’ACACAATGAACTCAATCATGACTACCCGTC3’) as described by Snou-
nou [21]. The cycling conditions were as follows: denaturation, 95˚C for 5 min; 35 cycles of
94˚C for 30 s, 56˚C for 30 s, and 60˚C for 60 s; and a final extension at 60˚C for 5 min. The
presence of amplification product is detected by simple ethidium bromide staining following
agarose gel electrophoresis and a 205 bp size of the PCR product confirms P. falciparum.
PCR-based genotyping of pfhrp2/3 deletions. Amplifications of exons 2 and their flank-
ing regions of pfhrp2/3 genes were done by semi-nested PCR [22] using published protocols
and primers (Table 1). Nest-1 PCR targets repeat sequences within the most variable part of
the genes while the second primer set targets an intron region. For pfhrp2, PCR nest-1 product
sizes of 720–830 bp were expected while for Pfhrp3, the expected PCR product size was< 500
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bp. The PCR products were purified by the GeneJet PCR Cleanup Kit from Thermo Fisher Sci-
entific and sent for sequence determination at Eurofins genomics, Germany. Sequences were
analysed by the 4peaks program (A. Griekspoor and Tom Groothuis, nucleobytes.com).
Amplification of pfhrp2/3 flanking regions
For amplifications of genes immediately flanking pfhrp2 (MAL7P1.230 (5.535 kb upstream)
and MAL7P1.228 (6.49 kb downstream)), and pfhrp3 (MAL13P1.485 (4.404 kb upstream) and
MAL13P1.475 (1.684 kb downstream)), the following primers and PCR conditions were used
(Table 2).
To rule out the possibility that the absence of amplification in pfhrp2/3 may be an artifact of
the PCR, alternative primers with different binding sites and amplification conditions were
used. All primers were used on samples from Tanzania with intact pfhrp2/3 genes with good
results. In addition, amplifications of pfmdr1 and pfubp-1 genes were successful in all samples
suggesting the deletion of pfhrp2/3 genes.
Ethical issue. The study was approved by Aklilu Lemma Institute of Pathobiology, Addis
Ababa University, Institutional review Board. Written consent and/or assent were obtained
from each study participant.
Table 1. Primers name and sequences used to amplify pfhrp2/3 genes including the flanking regions.
Primer name Gene Sequence (5’! 3’)
Hrp-2 outer (reverse primer) HRP2 5'-TCT ACA TGT GCT TGA GTT TCG-3'
Hrp-2 outer (forward primer) HRP2 5'-GGT TTC CTT CTC AAA AAA TAA AG-3'
Hrp-2 inner (forward primer) HRP2 5'- GTA TTA TCC GCT GCC GT TTT GCC-3'
Hrp-2 inner (reverse primer) HRP2 5'-CTA CAC AAG TTA TTATTA AAT GCG GAA- 3'
pfhrp2newoutfw HRP2 Fw: ATA TTT GCA CAT CTT GC
pfhrp2newoutrev HRP2 Rev: ATG GTT TCC TTC TCA AA
pfhrp2newnestfw HRP2 Fw: TCG CTA TCC CAT AAA TTA CA
pfhrp2newnestrev HRP2 Rev: GAT TAT TAC ACG AAA CTC AAG C
228 outer-forward 228 Fw: CAA TAG TTG CTT GTG CGG ATG
228 outer-reverse 228 Rev AGA AGT TGC AGA GAC ATA CTT AGG
228 nested-forward 228 Fw: AGA CAA GCT ACC AAA GAT GCA GGT
228 nested-reverse 228 Rev: TAA ATG TGT ATC TCC TGA GGT AGC
230 outer-forward 230 Fw: CCC TGC TAT ATA GAT GAG GAA A
230 outer-reverse 230 Rev: CTA CCA CTT CTG TTG CTA CC
230 nested forward 230 Fw: TAT GAA CGA AAT TTA AGT GAG GCA
230 nested-reverse 230 Rev: TAT CCA ATC CTT CCT TTG CAA CAC C
Hrp3 out rev new HRP3 5´-CCA TAC ACT TAT GCT GTA TTTA- 3´
Hrp3 outfw new HRP3 5´- TGG TAA TTT CTG TGT TTA TG- 3´
Hrp3-2 nestfw HRP3 5´- TAT CCG CTG CCG TTT TTG CTT CC- 3´
Hrp3 nest rev HRP3 5´- TGG TGT AAG TGA TGC GTA GT- 3´
MAL 475 REV set1 (out-rev) 475 5´-TCC CAC ATC GTA TAT CTC AGT TTC- 3´
MAL 475 FWD set1 (out-fw) 475 5´-GGA AAG CAC AAC AAG ATG GAT AC- 3´
MAL 13PI 475 rev (nest-rev) 475 5´-TCG TAC AAT TCA TCA TAC TCA CC- 3´
MAL 13PI 475 fw (nest-fw) 475 5´-TTC ATG AGT AGA TGT CCT AGG AG- 3´
MAL 485 REV set1 (out-rev) 485 5´-GCT TCT TTC CAC ATT TCT CAC AT- 3´
MAL 485 FWD set5 (out-fw) 485 5´-GTG TGT TTC CAT GTA TTA CGG AAG- 3´
MAL 12PI 485 rev (nest-rev) 485 5´-AAA TCA TTT CCT TTT ACA CTA GTG C- 3´
MAL 12PI 485 fw (nest-fw) 485 5´-TTG AGT GCA ATG ATGATG GGA G- 3´
https://doi.org/10.1371/journal.pone.0241807.t001
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Results
PCR confirmation of Plasmodium falciparum infections
Of 189 self-reporting febrile patients seeking malaria diagnosis at Adama Malaria Diagnostic
Centre, 33.9% (64/189) were positive for P. falciparum as confirmed by expert microscopy
which was later proven positive by PCR. The male: female ratio was 3.1:1. Participant’s mean
age was 25.2 years (range 11–48). The minimum parasite density reported was 400 parasites/
μL. Although all microscopically confirmed cases tested positive by PCR, only 50 samples had
enough DNA for further analysis of deletion in pfhrp2/3 genes and the flanking regions.
By targeting six regions in the pfhrp2/3 genes and their flanking genes, different deletion
patterns were observed in Ethiopian P. falciparum clinical samples. Most parasite isolates had
deleted the gene located 3’ of pfhrp2, PF3D7_0831900, compared to the flanking gene5’,
PF3D7_0831700. In contrast, the 5’ flanking PF3D7_1372100 gene, upstream of pfhrp3,
showed more deletions than the downstream 3’ flanking PF3D7_1372400 region. Combining
deletions in the genes and flanking regions, the most common pattern exhibited in the isolates
was the presence of the two flanking regions for pfhrp2 in combination with the downstream
flanking region for pfhrp3. This was followed by isolates that had a deleted downstream flank-
ing region of pfhrp3 but with the two flanking regions of pfhrp2 retained. Notably, only one
isolate showed intact flanking regions for both gene loci. Amplifications of pfmdr1 and pfubp-
1 genes in these samples are an indication that the absence of PCR products in the pfhrp2/3
genes and the respective flanking regions are due to deletions.
Genetic deletion of pfhrp2 and pfhrp3 and their flanking genes. The deletion variant at
pfhrp2 gene was fixed in the population analysed as the gene was deleted in all 50(100%) iso-
lates assessed. The deletion extended downstream pfhrp2 gene flanking region towards the
Pf3D7 0831900(MAL7PI.230) gene in 11/50 (22%) of the cases (Table 3). In contrast, only 2/50
(4%) of samples had deletions for the upstream gene Pf3D7 0831700(MALPI.228).
Similar results were observed for pfhrp3 and flanking regions. Here, all the isolates had
deletions in the pfhrp3 gene (100%). Like for pfhrp2 gene, pfhrp3 deletion extended to the
downstream flanking region to include Pf3D7 13272400 (MAL13PI.485) in 40% of samples.
However, the extension of the deletion was more prevalent upstream towards Pf3D7
081372100 (MAL13PI.475), with 49/50 (95%) of isolates deleted at these loci.
The summary of deletions in pfhrp2 and pfhrp3 genes and the respective flanking regions
are indicated in S1 File.
In addition to the exon primers that cover the normally analysed variable region, a set of
primers targeting an intron sequence with a varying number of AT repeats. In spite of the neg-
ative results for all samples in exon-based PCR, five samples actually gave PCR products for
the intron region. The samples contained different numbers of AT repeat sequence motif (one
Table 2. PCR conditions and expected product sizes of the pfhrp2/3 flanking regions.
Gene PCR conditions Expected PCR product
size
MAL7P1_228 94˚C for 10 min, followed by 94˚C for 30 sec, 60˚C for 30 sec, 68˚C for
1 min
227 bp
MAL7P1_230 94˚C for 10 min, followed by 94˚C for 30 sec, 60˚C for 30 sec, 68˚C for
1 min
346 bp
MAL13P1_475 94˚C for 10 min, followed by94˚Cfor 30 sec, 60˚C for 30 sec, 68˚C for
1 min
260 bp
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Table 3. Extension of deletions of pfhrp 2 and pfhrp3 genes, the respective flanking regions and exon primers used in Ethiopian isolates.
DNA sample ID. Gene 228 pfhrp2 Gene 230 Gene 475 pfhrp3 Gene 485
1 + - - - - +
2 + - - - - +
3 + - + - - -
4 + - + - - +
5 + - + - - +
6 + - + - - +
7 + - + - - +
8 + - + (+) - +
9 + - + - - +
10 + - + - - +
11 + - + - - +
12 + - + - - -
13 + - + - - -
14 + - - - - -
15 + - + - - +
16 + - - - - +
17 + - - - - +
18 + - - - - +
19 + - + - - +
20 + - + - - -
21 + - + - - -
22 + - + - - -
23 + - + - - -
24 + - + - - -
25 + - - - - -
26 + - + - - +
27 + - + - - +
28 + - - - - +
29 + - + - - +
30 + - + - - -
31 + - + - - -
32 + - + - - -
33 - - + - - -
34 - - + - - -
35 + - + - - -
36 + - - - - -
37 + - + - - +
38 + - + - - -
39 + - - - - +
40 + - - - - +
41 + - + - - +
42 + - + - - +
43 + - + - - +
44 + - + - - +
45 + - + - - +
46 + - + - - -
47 + - + - - -
(Continued)
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sample with 10 repeats, and four samples with 17 repeats) and suggest that the deletion in this
region did not involve the entire region (Table 4).
Discussion
As per WHO which hosted a technical consultation on pfhrp2/3 gene deletions and drafted
interim guidance for investigating false-negative RDTs [23], understanding the distribution
and evolution of these mutant parasites is a priority. However, it is yet unknown whether
reliance on PfHRP2-based RDTs to guide treatment across malaria endemic countries is
exerting evolutionary pressure favouring the spread of this mutation. At present, PfHRP2-
based RDTs are central to malaria control programmes in spite of the threat by parasites that
do not express PfHRP2. This study is the first to report the presence of extensive deletion of
pfhrp2 gene including deletion in its structural homolog, pfhrp3, in clinical isolates in
Ethiopia
All 50 samples (100%) yielded deletion for pfhrp2 and pfhrp3 genes. In pfhrp2 gene, the
deletion extended to 4% (2/50) of flanking region gene 228. Flanking region gene 230 con-
tained deletions in 22% (11/50) of the samples. Around pfhrp3 genes 475 and 485 were deleted
for 95% and 40% of the samples, respectively. The fact that HRP2-based RDTs tests accounted
for 74% of malaria diagnostic testing in the sub-Saharan Africa in 2017 [24], such massive utili-
zation of RDTs could lead to selection and spread of P. falciparum strains that can evade detec-
tion through the deletion of the pfhrp2 genes.
Nowadays, a great concern with the use of PfHRP2-based RDTs malaria diagnosis has been
the evolving reports of P. falciparum isolates lacking the pfhrp2 and pfhrp3 genes, which
respectively encode the PfHRP2 and the PfHRP3 proteins [12,25,26]. The deletion assay
includes six targets of pfhrp2/3 and flanking regions, and at least one locus was amplified for
50 samples out of 64 microscopically and PCR confirmed P. falciparum clinical samples col-
lected. While the deletion in pfhrp2 gene extended downstream in 11/50 (22%) of the isolates,
the deletion was only 4% in upstream of pfhrp2. However, it is unclear if these pfhrp2 deletions
are recent events or emerged prior to the introduction of PfHRP2-based RDTs in Ethiopia. In
Peru, for instance, pfhrp2-deleted parasites were present before the introduction of RDTs, but
the sweep in the population that occurred after RDT introduction shows the strength of
Table 3. (Continued)
DNA sample ID. Gene 228 pfhrp2 Gene 230 Gene 475 pfhrp3 Gene 485
48 + - + - - -
49 + - + - - +
50 + - + - - +
https://doi.org/10.1371/journal.pone.0241807.t003
Table 4. Repeat sequences in pfhrp2 intron, in 50 Ethiopian samples tested, those not listed did not give PCR
products.
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selection against this new diagnostic tool [27]. It is indicated that the extensive use of
PfHRP2-based RDTs is sufficient to select P. falciparum parasites lacking this protein [15].
Similarly, deletion was evident in 100% of the isolates analysed in pfhrp3 gene and extended
to the downstream flanking region that codes for Pf3D7 13272400 (MAL13PI.485) gene in
40% of the isolates. The pfhrp3 deletion also extended upstream to Pf3D7 081372100
(MAL13PI.475) region in 49/50 (95%) of the isolates, exhibiting complete absence of the locus.
Two distinct repeat motifs were observed for pfhrp2 intron region in 50 of the samples tested
suggesting that the deletion in this region did not involve the entire region.
Interestingly, PfHRP2-based RDTs are far more popular in Ethiopia than pLDH-based
RDTs, partly because of their higher sensitivity for P. falciparum diagnosis. The presence of
deletions in both pfhrp2 and pfhrp3 genes suggest that this could have been a result of a recent
selection as a consequence of the widely used PfHRP2-based RDTs. The possible spread of
pfhrp2/3 deleted parasite from a neighbour country like Eritrea can’t be overlooked for the
presence high deletions in Ethiopian P. falciparum populations. Very high frequencies of these
deletions have also been reported in Eritrea, a close geographic population and neighbour to
Ethiopian parasite populations [13,14]. Deletions in both genes are less frequent in other Afri-
can populations, though this phenomenon is quite prevalent in South American countries
[27,28]. Recent whole genome analysis of P. falciparum across Africa countries found isolates
from Ethiopia to be highly divergent from the rest of continent, defining a genomic back-
ground that could respond differently to selective forces such as RDTs and drugs [20]. These
deletion isolates formed a closely related cluster probably from clonal proliferation of a recent
pfhrp2-deleted ancestor [27]. Expansion of these deleted isolates could jeopardise the effective-
ness of PfHRP2-based RDTs.
RDT-based malaria diagnosis followed by treatment could be selectively clearing infections
with parasites retaining the pfhrp2/3 genes and hence increase the rate of spread of parasites
with deletions [29]. When the pfhrp2 gene deletion was reported in 2010 in South America,
this led to the recommendation against the use of PfHRP2-based RDTs in these areas [30–32].
If the results here are corroborated in a larger study across Ethiopia, a similar recommendation
may be warranted. Unfortunately, patient recruitment in this study was based on microscopy
and this does not allow us to determine the outcome of PfHRP2/3-based RDT for P. falciparum
population with complete deletion of pfhrp2/3 genes. Hence, further large-scale studies using
microscopy and PfHRP2/3-based RDTs are required to validate these high frequencies of
pfhrp2/3 gene deletions and their effect on RDT malaria diagnosis in Ethiopia. For now, poly-
morphisms in pfhrp2/3 genes in Ethiopian isolates don’t seem to influence performance of cur-
rently used PfHRP2 RDTs given that they have been widely used in the country. Furthermore,
as the samples were collected from one location in Ethiopia, a geographically expanded study
would better inform the national malaria control program (NMCP) on need for reviewing pol-
icy on type of mRDTs in the country and the extent of pfhrp2/3 genes deletions.
This study has several important limitations. The samples were collected during a single
malaria transmission season spanning September through December 2015 from one study
site. Hence, the results here can’t be generalized to the clinical isolates from other endemic
areas of Ethiopia. The number of isolates analysed was also small in number (50 P. falciparum
clinical isolates). The fact that the clinical samples were collected using microscopy alone, it is
impossible to know if the deleted isolates would test negative or positive for RDTs in the
absence of pfhrp2/3 genes as we didn’t perform RDT-based diagnosis.
In summary, P. falciparum parasite populations with deletions of the pfhrp2 and pfhrp3
genes are present in Adama site of Ethiopia. Continuous monitoring of deletions among clini-
cal isolates in the target regions is important in this era of malaria elimination, which largely
depends on RDTs.
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Supporting information
S1 File. Summary of pfhrp2, pfhrp3 amplification and their respective flanking genes in P.
falciparum samples collected in Ethiopia.
(PDF)
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